95 related articles for article (PubMed ID: 25178198)
41. Hepatic iron content is independently associated with serum hepcidin levels in subjects with obesity.
Moreno-Navarrete JM; Moreno M; Puig J; Blasco G; Ortega F; Xifra G; Ricart W; Fernández-Real JM
Clin Nutr; 2017 Oct; 36(5):1434-1439. PubMed ID: 27745814
[TBL] [Abstract][Full Text] [Related]
42. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
43. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.
Takasawa K; Takaeda C; Maeda T; Ueda N
Nutrients; 2014 Dec; 7(1):103-18. PubMed ID: 25551249
[TBL] [Abstract][Full Text] [Related]
44. Increased risk of iron deficiency and reduced iron absorption but no difference in zinc, vitamin A or B-vitamin status in obese women in India.
Herter-Aeberli I; Thankachan P; Bose B; Kurpad AV
Eur J Nutr; 2016 Dec; 55(8):2411-2421. PubMed ID: 26454657
[TBL] [Abstract][Full Text] [Related]
45. Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseases.
Lefebvre T; Lasocki S; Fénéant-Thibault M; Lamy PJ; Cunat S; Ropert-Bouchet M; Aguilar-Martinez P; Lehmann S; Delaby C
Ann Biol Clin (Paris); 2017 Feb; 75(1):9-18. PubMed ID: 28132948
[TBL] [Abstract][Full Text] [Related]
46. Oxidative stress, hepcidin and nesfatin-I status in childhood iron and vitamin B12 deficiency anemias.
Aşkar TK; Büyükleblebici O; Hismioğulları AA; Hünkerler Z
Adv Clin Exp Med; 2017 Jul; 26(4):621-625. PubMed ID: 28691407
[TBL] [Abstract][Full Text] [Related]
47. Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification.
Durigova A; Lamy PJ; Thezenas S; Pouderoux S; Montels F; Romieu G; Gutowski M; Jacot W
Clin Chem Lab Med; 2013 Sep; 51(9):1833-41. PubMed ID: 23787470
[TBL] [Abstract][Full Text] [Related]
48. Anemia and Iron Deficiency in Children With Potential Celiac Disease.
Repo M; Lindfors K; Mäki M; Huhtala H; Laurila K; Lähdeaho ML; Saavalainen P; Kaukinen K; Kurppa K
J Pediatr Gastroenterol Nutr; 2017 Jan; 64(1):56-62. PubMed ID: 27101536
[TBL] [Abstract][Full Text] [Related]
49. Effect of iron liposomes on anemia of inflammation.
Yuan L; Geng L; Ge L; Yu P; Duan X; Chen J; Chang Y
Int J Pharm; 2013 Sep; 454(1):82-9. PubMed ID: 23850818
[TBL] [Abstract][Full Text] [Related]
50. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity.
Andrews M; Soto N; Arredondo-Olguín M
Nutrition; 2015 Jan; 31(1):51-7. PubMed ID: 25441587
[TBL] [Abstract][Full Text] [Related]
51. Effects of iron supplementation in mice with hypoferremia induced by obesity.
Gotardo ÉM; Caria CR; de Oliveira CC; Rocha T; Ribeiro ML; Gambero A
Exp Biol Med (Maywood); 2016 Dec; 241(18):2049-2055. PubMed ID: 27439539
[TBL] [Abstract][Full Text] [Related]
52. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
53. Conventional and novel peripheral blood iron markers compared against bone marrow in Malawian children.
Jonker FA; Boele van Hensbroek M; Leenstra T; Vet RJ; Brabin BJ; Maseko N; Gushu MB; Emana M; Kraaijenhagen R; Tjalsma H; Swinkels DW; Calis JC
J Clin Pathol; 2014 Aug; 67(8):717-23. PubMed ID: 24915849
[TBL] [Abstract][Full Text] [Related]
54. Hepcidin-25 vs. conventional clinical biomarkers in the diagnosis of functional iron deficiency.
Enko D; Wagner H; Kriegshäuser G; Kimbacher C; Stolba R; Worf E; Halwachs-Baumann G
Eur J Haematol; 2015 Dec; 95(6):507-13. PubMed ID: 25598480
[TBL] [Abstract][Full Text] [Related]
55. IL-22 regulates iron availability in vivo through the induction of hepcidin.
Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR
J Immunol; 2013 Aug; 191(4):1845-55. PubMed ID: 23836059
[TBL] [Abstract][Full Text] [Related]
56. The role of Matriptase-2 during the early postnatal development in humans.
De Falco L; Bruno M; Yilmaz-Keskin E; Sal E; Büyükavci M; Kaya Z; Girelli D; Iolascon A
Haematologica; 2016 Apr; 101(4):e126-8. PubMed ID: 26802052
[No Abstract] [Full Text] [Related]
57. Iron biology, immunology, aging, and obesity: four fields connected by the small peptide hormone hepcidin.
Dao MC; Meydani SN
Adv Nutr; 2013 Nov; 4(6):602-17. PubMed ID: 24228190
[TBL] [Abstract][Full Text] [Related]
58. [Iron deficiency reduces systemic inflammation in obese women].
Nedoborenko VM; Lavrenko AV; Mamontova TV; Vesnina LE; Kaidashev IP
Wiad Lek; 2018; 71(2 pt 2):326-330. PubMed ID: 29786580
[TBL] [Abstract][Full Text] [Related]
59. Hepcidin: a real-time biomarker of iron need.
Hare DJ
Metallomics; 2017 Jun; 9(6):606-618. PubMed ID: 28470295
[TBL] [Abstract][Full Text] [Related]
60. Obesity and iron deficiency: a quantitative meta-analysis.
Zhao L; Zhang X; Shen Y; Fang X; Wang Y; Wang F
Obes Rev; 2015 Dec; 16(12):1081-93. PubMed ID: 26395622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
